Surgical Science Sweden Stock Today
| SUSRF Stock | USD 12.75 0.00 0.00% |
Performance1 of 100
| Odds Of DistressLess than 9
|
Surgical Science is trading at 12.75 as of the 28th of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 12.75. Surgical Science has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. Equity ratings for Surgical Science Sweden are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of December 2022 and ending today, the 28th of November 2024. Click here to learn more.
Surgical Science Sweden AB develops and markets virtual reality simulators for evidence-based laparoscopic and endoscopic training. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden. Surgical Science is traded on OTC Exchange in the United States. The company has 50.8 M outstanding shares. More on Surgical Science Sweden
Moving against Surgical Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Surgical Pink Sheet Highlights
| Business Concentration | Health Information Services, Healthcare (View all Sectors) |
Surgical Science Sweden [SUSRF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Small-Cap' category with a current market capitalization of 833.72 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Surgical Science's market, we take the total number of its shares issued and multiply it by Surgical Science's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Surgical Science Sweden classifies itself under Healthcare sector and is part of Health Information Services industry. The entity has 50.8 M outstanding shares.
Surgical Science generates positive cash flow from operations, but has no cash available
Check Surgical Science Probability Of Bankruptcy
Ownership AllocationSurgical Science Sweden shows a total of 50.8 Million outstanding shares. Over half of Surgical Science's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Surgical Ownership Details
Surgical Science Sweden Risk Profiles
| Mean Deviation | 0.5762 | |||
| Standard Deviation | 1.96 | |||
| Variance | 3.85 | |||
| Risk Adjusted Performance | (0.01) |
Surgical Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Surgical Science without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Surgical Science Corporate Management
| Inbal MazorBadichi | VP Marketing | Profile | |
| Ran Bronstein | Pres RD | Profile | |
| Anna Ahlberg | Chief Officer | Profile | |
| Adv | Chief Officer | Profile | |
| Daniel Evestedt | Head Devel | Profile | |
| Jeffrey Berkley | Chief Officer | Profile | |
| Martin Jansson | Head Sales | Profile |
Other Information on Investing in Surgical Pink Sheet
Surgical Science financial ratios help investors to determine whether Surgical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Surgical with respect to the benefits of owning Surgical Science security.